.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Harvard Business School
UBS
US Department of Justice
Medtronic
Fuji
McKinsey
Chubb
Deloitte
Baxter

Generated: December 15, 2017

DrugPatentWatch Database Preview

Oxycodone - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxycodone and what is the scope of oxycodone freedom to operate?

Oxycodone
is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Ani Pharms Inc, Avanthi Inc, Lannett Holdings Inc, Lehigh Valley, Mayne Pharma Inc, Novel Labs Inc, Abhai Llc, Ascent Pharms Inc, Hi-tech Pharmacal, Pharm Assoc, Vistapharm, Wes Pharma Inc, West-ward Pharms Int, Wockhardt Bio Ag, Purdue Pharma Lp, Roxane, Egalet Us Inc, Actavis Elizabeth, Alvogen Malta, Amneal Pharms, Aurolife Pharma Llc, Epic Pharma Llc, Ken Lifescience, Mallinckrodt Inc, Nesher Pharms, Rhodes Pharms, Sun Pharm Inds Inc, Vintage Pharms, and Daiichi Sankyo Inc, and is included in forty-six NDAs. There are thirty-nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxycodone has fourteen patent family members in five countries and one supplementary protection certificate in one country.

There are seventeen drug master file entries for oxycodone. Two suppliers are listed for this compound. There are four tentative approvals for this compound.

Pharmacology for oxycodone

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Medical Subject Heading (MeSH) Categories for oxycodone

Tentative approvals for OXYCODONE

Applicant Application No. Strength Dosage Form
u► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe40MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Nesher PharmsOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL077290-002Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Collegium Pharm IncXTAMPZA ERoxycodoneCAPSULE, EXTENDED RELEASE;ORAL208090-005Apr 26, 2016RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Collegium Pharm IncXTAMPZA ERoxycodoneCAPSULE, EXTENDED RELEASE;ORAL208090-005Apr 26, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-004Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-002Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Mallinckrodt IncROXICODONEoxycodone hydrochlorideTABLET;ORAL021011-002Aug 31, 2000ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-002Apr 5, 2010RXYesNo► Subscribe► Subscribe► SubscribeYY► Subscribe
Avanthi IncOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL091393-005Aug 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Purdue Pharma LpOXYCONTINoxycodone hydrochlorideTABLET, EXTENDED RELEASE;ORAL022272-001Apr 5, 2010RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethOXYCODONE HYDROCHLORIDEoxycodone hydrochlorideTABLET;ORAL076636-001Feb 6, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: oxycodone

Country Document Number Estimated Expiration
Japan2009298822► Subscribe
Japan2015166402► Subscribe
European Patent Office1594467► Subscribe
Australia2003247876► Subscribe
World Intellectual Property Organization (WIPO)2004004693► Subscribe
Japan2017101075► Subscribe
European Patent Office1765292► Subscribe
World Intellectual Property Organization (WIPO)2005123039► Subscribe
Japan2013216707► Subscribe
Japan4694207► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OXYCODONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Harvard Business School
Express Scripts
Healthtrust
Boehringer Ingelheim
McKinsey
QuintilesIMS
Medtronic
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot